| 1 |
32790250 | Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression. | 2020 Aug |
17 |
| 2 |
28974549 | Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia. | 2017 Dec 15 |
4 |
| 3 |
29871174 | [Effects of dihydroartemisinin on the apoptosis of Fadu cells]. | 2016 Nov 5 |
1 |
| 4 |
26722323 | Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells. | 2015 Nov |
1 |
| 5 |
26788167 | Upregulation of the MCL-1S protein variant following dihydroartemisinin treatment induces apoptosis in cholangiocarcinoma cells. | 2015 Dec |
9 |
| 6 |
22342732 | Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. | 2012 May 1 |
5 |
| 7 |
21336837 | Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo. | 2011 May |
2 |